ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,459,981, issued on Nov. 4, was assigned to ImmunityBio Inc. (San Diego).
"Primary NK CAR constructs and methods" was invented by Fereshteh Parviz (San Diego) and Rohit Duggal (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are recombinant nucleic acids, comprising a 5' untranslated (5'-UTR) sequence portion, a signal peptide sequence portion, a single chain antibody fragment sequence portion, a hinge region sequence portion, a transmembrane domain sequence portion, and one or more intracellular domain sequence portions. Also disclosed herein are modified natural killer (NK) cells comprising the recombinant nucleic acid describe...